Hematology Expert Witnesses in Tennessee

This expert in Internal Medicine completed medical school abroad in India and completed his Residency in Internal Medicine at the University of New Mexico. He is board certified in Internal Medicine and is a member of the Society of Hospital Medicine. He has 6 publications and is currently a Hospitalist at a medical center in MO.

This expert is Board Certified in Pediatric Hematology-Oncology and Pathology, completing Fellowships in Pediatric Hematology/Oncology/BMT and Transfusion Medicine at Emory University School of Medicine. She is a member of the American Academy of Pediatric Hematology/Oncology and the American Society of Hematology, and has 50 publications in the field of Pediatric Hematology/Oncology. She is a former Assistant Professor of Pathology and Pediatrics at Emory University, and currently is the Medical Director of Blood and Tissue Services, along with being an Associate Professor of both Pathology and Pediatrics at a top medical university.

This highly qualified, triple board certified doctor completed his medical school at the American University of Beirut (AUB). He subsequently joined the internal medicine residency program at Wayne State University. After completion of the residency, he joined the hematology oncology fellowship program at the Karmanos Cancer Institute, also at Wayne State University. He then joined faculty as an Assistant Professor in the area of GI oncology. During this time, he was involved in translational research focused on pancreatic cancer. Immediately following his time at Wayne state, this doctor moved to his current position at a GA university as the director of the GI Oncology program . He is designated as a Distinguished Cancer Scholar by the Georgia Cancer Coalition. He is also currently the medical director of the Clinical Trials Office, where his mission relies on translational projects related to gastrointestinal malignancies, specifically pancreatic and colorectal cancer, to bring observations derived from invitro models of cancer cell growth to the clinic. He has over 150 peer reviewed publications, and is the lead clinical investigator on at least eight trials focused on the evaluation of novel treatments in patients with early stage or advanced cancer.